Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPK1 | P28482 | 1/20 | 0.41 |
| ▸ | LGALS1 | P09382 | 2/20 | 0.38 |
| ▸ | LGALS3 | P17931 | 2/20 | 0.38 |
| ▸ | LGALS9 | O00182 | 1/20 | 0.38 |
| ▸ | LGALS8 | O00214 | 1/20 | 0.38 |
| ▸ | PYGB | P11216 | 1/20 | 0.34 |
| ▸ | SLC2A1 | P11166 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | THRB | P10828 | 1/20 | 0.33 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.33 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11199589 | 1.00 | MAPK1 (0.41) | MAPK1LGALS1LGALS3LGALS9LGALS8 | |
| SCHEMBL16026724 | 1.00 | MAPK1 (0.41) | MAPK1LGALS1LGALS3LGALS9LGALS8 | |
| SCHEMBL143296 | 1.00 | MAPK1 (0.41) | MAPK1LGALS1LGALS3LGALS9LGALS8 | |
| SCHEMBL9705418 | 0.81 | LGALS3 (0.41) | MAPK1LGALS1LGALS3LGALS9LGALS8 | |
| SCHEMBL9838031 | 0.79 | PTPN1 (0.38) | MAPK1LGALS1LGALS3LGALS9 | |
| SCHEMBL7164875 | 0.79 | PTPN1 (0.38) | MAPK1LGALS1LGALS3LGALS9 | |
| SCHEMBL3181367 | 0.78 | L3MBTL1 (0.47) | LGALS1LGALS3LGALS9LGALS8L3MBTL1 | |
| SCHEMBL31019382 | 0.78 | L3MBTL1 (0.47) | LGALS1LGALS3LGALS9LGALS8L3MBTL1 | |
| SCHEMBL3519225 | 0.78 | L3MBTL1 (0.47) | LGALS1LGALS3LGALS9LGALS8L3MBTL1 | |
| SCHEMBL8343760 | 0.78 | LGALS3 (0.39) | MAPK1LGALS1LGALS3LGALS9LGALS8 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 356 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1127142-B1 | MODULATION OF POLYPEPTIDE DISPLAY ON MODIFIED FILAMENTOUS PHAGE | SCRIPPS RESEARCH INST (US) | 2009-05-06 | — | — | EP | claimed |
| US-20240139148-A1 | COMPOSITIONS AND METHODS FOR TREATING NON-TUBERCULOUS MYCOBACTERIAL INFECTIONS | COLORADO STATE UNIVERSITY RESEARCH FOUNDATION | 2024-05-02 | — | — | US | disclosed |
| US-20240038331-A1 | Self-Assembling Protein Nanostructures | UNIV WASHINGTON THROUGH ITS CENTER FOR COMMERCIALIZATION (US) | 2024-02-01 | — | — | US | disclosed |
| WO-2024016397-A1 | LYTIC POLYSACCHARIDE MONOOXYGENASE FROM BACILLUS SUBTILIS AND USE THEREOF | 浙江大学 | 2024-01-25 | — | — | WO | disclosed |
| CN-113227377-B | DNA aptamer specifically combined with yellow fever virus EDIII and application thereof | MD保健株式会社 | 2023-11-28 | — | — | CN | disclosed |
| CN-111212910-B | DNA aptamer specifically binding to CFP10 and application thereof | MD奥图斯公司 | 2023-11-24 | — | — | CN | disclosed |
| EP-4275759-A2 | QUINOLINE DERIVATIVES AS CHROMOBOX (CBX) PROTEIN INHIBITORS FOR TREATING CANCER | Dana-Farber Cancer Institute, Inc. (US) | 2023-11-15 | — | — | EP | disclosed |
| CN-111212911-B | DNA aptamer specifically binding to TB7.7 and application thereof | MD奥图斯公司 | 2023-09-22 | — | — | CN | disclosed |
| EP-3515449-B1 | QUINOLINE DERIVATIVES AS CHROMOBOX (CBX) PROTEIN INHIBITORS FOR TREATING CANCER | DANA FARBER CANCER INST INC (US) | 2023-07-12 | — | — | EP | disclosed |
| US-20230159595-A1 | POLYPEPTIDES FOR USE IN SELF-ASSEMBLING PROTEIN NANOSTRUCTURES | UNIVERSITY OF WASHINGTON | 2023-05-25 | — | — | US | disclosed |
| EP-0355720-A1 | Process for the preparation of motilin-like polypeptide and expression thereof | SANWA KAGAKU KENKYUSHO CO., LTD. (JP) | 1990-02-28 | — | — | EP | disclosed |
| EP-0294469-A4 | VACCINES AND DIAGNOSTIC ASSAYS FOR HAEMOPHILUS INFLUENZAE. | PRAXIS BIOLOG INC (US) | 1990-02-05 | — | — | EP | disclosed |
| EP-0345021-A2 | Poultry mycoplasma antigens and recombinant vectors containing the gene as well as diagnostics and vaccines utilizing the same | NIPPON ZEON CO., LTD. (JP) | 1989-12-06 | — | — | EP | disclosed |
| WO-1989009260-A1 | RYEGRASS POLLEN ALLERGEN | THE UNIVERSITY OF MELBOURNE (AU) | 1989-10-05 | — | — | WO | disclosed |
| EP-0306524-A1 | ANTIGENIC DETERMINANTS RECOGNIZED BY ANTIBODIES OBTAINED USING A PATHOGENIC AGENT OR A DERIVATIVE THEREOF THAT PRESENTS A RESTRICTED SET OF ANTIGENS | The Department of the Army Engineer Research and Development Center, Corps of Engineers (US) | 1989-03-15 | — | — | EP | disclosed |
| EP-0294469-A1 | VACCINES AND DIAGNOSTIC ASSAYS FOR HAEMOPHILUS INFLUENZAE. | PRAXIS BIOLOG INC (US) | 1988-12-14 | — | — | EP | disclosed |
| WO-1988006892-A1 | ANTIGENIC DETERMINANTS RECOGNIZED BY ANTIBODIES OBTAINED USING A PATHOGENIC AGENT OR A DERIVATIVE THEREOF THAT PRESENTS A RESTRICTED SET OF ANTIGENS | UNITED STATES OF AMERICA, AS REPRESENTED BY THE SE (US) | 1988-09-22 | — | — | WO | disclosed |
| WO-1988004932-A1 | VACCINES AND DIAGNOSTIC ASSAYS FOR HAEMOPHILUS INFLUENZAE | PRAXIS BIOLOGICS, INC. (US) | 1988-07-14 | — | — | WO | disclosed |
| WO-1987005628-A1 | MINACTIVIN PRODUCED BY RECOMBINANT DNA TECHNOLOGY | BIOTECHNOLOGY AUSTRALIA PTY. LTD. (AU) | 1987-09-24 | — | — | WO | disclosed |
| EP-0238275-A2 | Recombinant product | BIOTECHNOLOGY AUSTRALIA PTY. LTD. (AU) | 1987-09-23 | — | — | EP | disclosed |